½ÃÀ庸°í¼­
»óǰÄÚµå
1529983

À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå : À¯Çüº°, Á¦Ç°º°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Genetic Toxicology Testing Market, By Type, By Product, By End User, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

¼¼°è À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀåÀº 2024³â 14¾ï 1,000¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024-2031³â°£ CAGR 13.1%·Î ¼ºÀåÇÏ¿© 2031³â¿¡´Â 33¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼³»¿ë
±âÁس⵵ 2023³â 2024³â ½ÃÀå ±Ô¸ð 14¾ï 1,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2019-2023³â ¿¹Ãø ±â°£ 2024-2031³â
¿¹Ãø ±â°£(2024-2031³â) CAGR 13.10% 2031³â ±Ý¾× Àü¸Á 33¾ï 3,000¸¸ ´Þ·¯
±×¸². 2024³â Áö¿ªº° À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå Á¡À¯À²(%)
Genetic Toxicology Testing Market-IMG1

¼¼°è À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀåÀº ¿ª»çÀû ±â°£(2019-2028³â)¿¡ ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸¿´À¸¸ç, ¿¹Ãø ±â°£(2024-2031³â)¿¡´Â Ç÷¯½º ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ÁÖ·Î È­Çй°Áú ¹× ¼ÒºñÀÚ Á¦Ç°ÀÇ ¾ÈÀü¼º Æò°¡¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³±â ¶§¹®ÀÎ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù. ¾Ï °ü·Ã Áúȯ Áõ°¡, ƯÈ÷ Á¦¾à »ê¾÷ÀÇ ¾ö°ÝÇÑ ±ÔÁ¦, °í¼º´É ±â¼úÀÇ ±Þ¼ÓÇÑ ¹ßÀü°ú °°Àº ¿äÀεéÀº À¯Àüµ¶¼º Å×½ºÆ® »ê¾÷¿¡ Å« ¿µÇâÀ» ¹ÌÄ¡´Â µ¿ÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀÔ´Ï´Ù. ±×·¯³ª À¯Àüµ¶¼º Æò°¡ÁöÇ¥ÀÇ Æò°¡¿Í °ü·ÃµÈ º¹À⼺Àº ½ÃÀå ¼ºÀåÀ» ¾î´À Á¤µµ Á¦ÇÑÇϰí ÀÖ½À´Ï´Ù. ÀüüÀûÀ¸·Î ¼¼°è À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀåÀº 2024-2031³â »çÀÌ 13.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

½ÃÀå ¿ªÇÐ :

À¯ÀüÀÚ µ¶¼º °Ë»ç ¼¼°è ½ÃÀåÀº ¼¼°è ¾Ï ¹ßº´·ü Áõ°¡·Î ÀÎÇØ ¾ÈÀüÇÑ È­Çй°Áú/ÀǾàǰ °³¹ßÀ» À§ÇÑ Á¦¾à ¹× »ý¸í°øÇÐ ºÎ¹® ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, WHO¿¡ µû¸£¸é 2040³â±îÁö ¾Ï ȯÀÚ ¼ö´Â 2,750¸¸ ¸í, ¾Ï »ç¸ÁÀÚ ¼ö´Â 1,630¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ°í ÀÖ½À´Ï´Ù. 630¸¸ ¸í¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøÇß½À´Ï´Ù. ¶ÇÇÑ, ¹Ì±¹ ½ÄǰÀǾ౹(USFDA)°ú °°Àº ±ÔÁ¦ ±â°üÀÌ Á¶±â ¾ÈÀü¼º Æò°¡¸¦ Àǹ«È­ÇÏ´Â ¾ö°ÝÇÑ °¡À̵å¶óÀÎÀÌ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ±×·¯³ª ÀüÀÓ»ó Æò°¡¿¡¼­ À¯Àüµ¶¼º Æò°¡º¯¼ö¸¦ ÇØµ¶ÇÏ´Â °ÍÀÌ º¹ÀâÇϰí ÀüÅëÀûÀÎ °Ë»ç¹ýÀÇ ±â¼úÀû ÇѰè·Î ÀÎÇØ ½ÃÀå ¼ºÀå¿¡ ¾î·Á¿òÀ» °ÞÀ» ¼ö ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå °³Ã´ ±â¾÷µéÀº ÀÌ·¯ÇÑ ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ °í¼º´É ½ºÅ©¸®´× ºÐ¼®¹ý ¹× ¼­ºñ½º °³¹ßÀ» À§ÇÑ ¿¬±¸°³¹ß¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

ÀÌ º¸°í¼­´Â ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀåÀ» »ó¼¼ÇÏ°Ô ºÐ¼®ÇßÀ¸¸ç, 2023³âÀ» ±âÁØ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â) ½ÃÀå ±Ô¸ð(¹ÌÈ­ 10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ ÁÖ¿ä °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú ¹× Àü·«°ú °°Àº ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è À¯Àüµ¶¼º Å×½ºÆ® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À» ÇÁ·ÎÆÄÀϸµÇÕ´Ï´Ù.

Á¶»ç ´ë»ó ÁÖ¿ä ±â¾÷À¸·Î´Â Charles River, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Jubilant Life Sciences, Cyprotex, Merck KGaA, Gentronix, BioReliance, Creative Biolabs, BioReliance, BioReliance, BioReliance, Creative Biolabs µîÀÌ ÀÖ½À´Ï´Ù. Limited, BioReliance, Creative Biolabs µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÅëÂû·ÂÀ» ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå, À¯Çüº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ü¿Ü
  • ü³»

Á¦6Àå ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå, Á¦Ç°º°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ½Ã¾à
  • ¼Ò¸ðǰ
  • ¾î¼¼ÀÌ
  • ¼­ºñ½º

Á¦7Àå ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • °è¾à¿¬±¸±â°ü
  • Á¦¾àȸ»ç
  • È­ÇÐȸ»ç
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ À¯ÀüÀÚ µ¶¼º °Ë»ç ½ÃÀå, Áö¿ªº°, 2019-2031³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Thermo Fisher Scientific, Inc.
    • WuXi AppTec
    • Charles River Laboratories International
    • Laboratory Corp of America Holdings
    • Eurofins Scientific
    • Jubilant Life Sciences Limited
    • Syngene International Limited
    • Gentronix Ltd.
    • Inotiv Inc.
    • Creative Bioarray
    • MB Research Laboratories
    • Molecular Toxicology, Inc.
    • Toxys
    • GeneTox Worldwide, Inc.

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • À¶¼º°ú ¼èÅð
  • COM(Coherent Opportunity Map)

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 24.08.26

The global genetic toxicology testing market is estimated to be valued at USD 1.41 Bn in 2024 and is expected to reach USD 3.33 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 13.1% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2024: US$ 1.41 Bn
Historical Data for: 2019 To 2023 Forecast Period: 2024 to 2031
Forecast Period 2024 to 2031 CAGR: 13.10% 2031 Value Projection: US$ 3.33 Bn
Figure. Genetic Toxicology Testing Market Share (%), By Region 2024
Genetic Toxicology Testing Market - IMG1

The global genetic toxicology testing market witnessed a steady growth during the historic period (2019-2028) and is projected to see positive gains in the forecast period (2024-2031). This can be primarily attributed to rising awareness about the safety assessment of chemicals and consumer products. Factors such as increasing instances of cancer related diseases, stringent regulations especially in pharmaceutical industry, and rapid advancements of high throughput technologies will serve as high impact rendering drivers for the genetic toxicology testing industry. However, complexities associated with the assessment of genotoxicity endpoints continue to restrict the market growth to a certain extent. Overall, the global genetic toxicology testing market is poised to exhibit a promising 13.1% CAGR during 2024-2031.

Market Dynamics:

The global genetic toxicology testing market is driven by rising incidences of cancer worldwide translating to the increasing demand from the pharmaceutical and biotechnology sectors for safe chemical/drug development. As per WHO, the cancer burden is projected to reach 27.5 million new cancer cases and 16.3 million cancer deaths by 2040. Furthermore, stringent guidelines mandating early safety assessment by regulatory bodies like USFDA, boosts adoption. However, market growth can be challenged due to complexities in deciphering genotoxicity endpoints during preclinical evaluation and technical limitations of few traditional testing methods. Key market players are investing in R&D to develop high throughput screening assays and services to address such issues opening opportunities.

Key Features of the Study:

This report provides in-depth analysis of the global genetic toxicology testing market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global Genetic Toxicology Testing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Charles River, Thermo Fisher Scientific, F. Hoffmann-La Roche Ltd, Jubilant Life Sciences, Cyprotex, Merck KGaA, Gentronix Limited, BioReliance, Creative Biolabs

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

The global genetic toxicology testing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global genetic toxicology testing market

Detailed Segmentation-

  • By Type
    • In Vitro
    • In Vivo
  • By Product
    • Reagents
    • Consumables
    • Assays
    • Services
  • By End User
    • Contract Research Organizations
    • Pharmaceutical Companies
    • Chemical Companies
    • Others
  • By Region:
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Thermo Fisher Scientific, Inc.
    • WuXi AppTec
    • Charles River Laboratories International
    • Laboratory Corp of America Holdings
    • Eurofins Scientific
    • Jubilant Life Sciences Limited
    • Syngene International Limited
    • Gentronix Ltd.
    • Inotiv Inc.
    • Creative Bioarray
    • MB Research Laboratories
    • Molecular Toxicology, Inc.
    • Toxys
    • GeneTox Worldwide, Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Type
    • Market Snapshot, By Product
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Genetic Toxicology Testing Market - Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Genetic Toxicology Testing Market, By Type, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • In Vitro
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • In Vivo
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

6. Global Genetic Toxicology Testing Market, By Product, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Reagents
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Consumables
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Assays
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Services
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

7. Global Genetic Toxicology Testing Market, By End User, 2019 - 2031, (USD Bn)

  • Overview
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2020 - 2031
    • Segment Trends
  • Contract Research Organizations
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Pharmaceutical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Chemical Companies
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Bn)

8. Global Genetic Toxicology Testing Market, By Region, 2019 - 2031, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2020-2031
    • Regional Trends
      • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019 - 2031, (USD Bn)
      • GCC
      • Israel
      • Rest of Middle East
      • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2019 - 2031, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019 - 2031, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Thermo Fisher Scientific, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • WuXi AppTec
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Charles River Laboratories International
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Laboratory Corp of America Holdings
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Eurofins Scientific
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Jubilant Life Sciences Limited
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Syngene International Limited
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Gentronix Ltd.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Inotiv Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Creative Bioarray
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • MB Research Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Molecular Toxicology, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Toxys
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GeneTox Worldwide, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. References and Research Methodology

  • References
  • Research Methodology
  • About Us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦